000 01486 a2200469 4500
005 20250515031356.0
264 0 _c20060628
008 200606s 0 0 eng d
022 _a0269-9702
024 7 _a10.1111/j.1467-8519.2006.00479.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEdwards, Sarah J L
245 0 0 _aRestricted treatments, inducements, and research participation.
_h[electronic resource]
260 _bBioethics
_cApr 2006
300 _a77-91 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aClinical Trials as Topic
_xethics
650 0 4 _aCoercion
650 0 4 _aDouble Effect Principle
650 0 4 _aDrug Approval
650 0 4 _aDrug Industry
650 0 4 _aDrugs, Investigational
_xeconomics
650 0 4 _aEthical Analysis
650 0 4 _aFreedom
650 0 4 _aGovernment Regulation
650 0 4 _aHealth Services Accessibility
_xeconomics
650 0 4 _aHuman Experimentation
_xethics
650 0 4 _aHumans
650 0 4 _aInformed Consent
650 0 4 _aInsurance Coverage
650 0 4 _aInternationality
650 0 4 _aMotivation
650 0 4 _aPaternalism
_xethics
650 0 4 _aPatients
650 0 4 _aPhilosophy
650 0 4 _aResearch Subjects
650 0 4 _aRisk Assessment
650 0 4 _aSocial Justice
650 0 4 _aVulnerable Populations
773 0 _tBioethics
_gvol. 20
_gno. 2
_gp. 77-91
856 4 0 _uhttps://doi.org/10.1111/j.1467-8519.2006.00479.x
_zAvailable from publisher's website
999 _c16366042
_d16366042